Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 8.238.9410.845.60-8.85

What is the latest Price to Cash Earnings (PCE) ratio of BAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of BAL PHARMA is 8.23 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20248.23
Mar20238.94
Mar202210.84
Mar20215.60
Mar2020-8.85

How is Price to Cash Earnings (PCE) of BAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 8.23
-7.94
Mar2023 8.94
-17.53
Mar2022 10.84
93.57
Mar2021 5.6
Positive
Mar2020 -8.85 -

Other Financial Ratios of BAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹193.5 Cr 46.3% 49.8% 11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,142.0 Cr -1.5% 9.1% 9.1% Stock Analytics
DIVIS LABORATORIES ₹145,762.0 Cr -4.9% -0.6% 59.1% Stock Analytics
CIPLA ₹114,322.0 Cr -1.8% 1% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,171.0 Cr 1.6% 12.1% 21.8% Stock Analytics
DR REDDYS LABORATORIES ₹92,603.7 Cr -3% -0.9% -7.7% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

46.3%

49.8%

11.6%

SENSEX

-2.9%

3.1%

1.8%


You may also like the below Video Courses